Highlights
- 1Children (Basel, Switzerland) · 2022
- 2Clinical obstetrics and gynecology · 2022
- 3JAMA network open · 2026
Publications
30 publications
Funding
1 grant
Completed grants (1)
- Co-IU19AI144301-02S1Immune Cells and Secretory Pathways Leading to Human Systemic AutoimmunityNational Institute of Allergy and Infectious Diseases · 2020–2024
Clinical research
6 studies
Active
4 studies- PICharacterization of nasopharyngeal immune responses and microbiome profiles in children with respiratory viral co-infectionsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
- PIRetrospective study of vaccine uptake and outcomes of vaccine-preventable infections in pediatricsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
- PIReducing unnecessary urine cultures through reflexive urine culture testing in childrenColumbia University · OPEN TO ACCRUAL (as of 2024)
- PIPocapavir for emergency compassionate use in a patient with enteroviral sepsis and endocarditisWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2019)
Completed & closed trials (2)
- PIOutcomes of Implementing Blood Culture Best Practices in the Management of Immunocompromised Pediatric PatientsMontefiore Medical Center · CLOSED TO ACCRUAL (as of 2025)
- PINCT04588363An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C)National Institute of Allergy & Infectious Diseases · CLOSED TO ACCRUAL (as of 2022)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); Multisystem Inflammatory Syndrome in Children (MIS-C); Coronavirus Disease 2019 (COVID-19)
News mentions
1 mentionView all WCM news ↗
- What to Know About the COVID-19 Vaccine and Young KidsNovember 12, 2021
About 28 million children became eligible for the COVID-19 vaccine after the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) approved and created guidelines for children ages 5 to 11 to receive the Pfizer/BioNTech COVID-19 vaccine. But as the vaccine rollout begins for younger kids, many parents may have questions.